IDH1 Antibody Immunohistochemistry on an FFPE Glioblastoma Tissue
|Intended Use||For In Vitro Diagnostic Use|
|Summary and Explanation|
IDH1 is an isocitrate dehydrogenase isozymes and encoded by the gene IDH1. IDH1 is involved in the citric acid cycle during glucose metabolism and catalyzes the oxidation of isocitrate to ⍺-ketoglutarate and reduction of NADP+ to NADPH. Both ⍺-ketoglutarate and NADPH play a role in protecting cells from oxidative stress and mitigating oxidative damage. Mutation in residue 132 of IDH1 results in loss of enzymatic function, build up of 2-hydroxyglutarate, and change in histone and DNA methylation.
Mutation of IDH1 is implicated in metaphyseal chondromatosis with aciduria as well as diffused gliomas and a number of neoplasms such as acute myeloid leukemia, acute lymphocytic leukemia, myelofibrosis, intrahepatic cholangiocarcinoma, melanoma, chondroid tumors, and certain rare forms of colonic and prostate carcinomas. However studies have shown that IDH1 mutation is not a direct trigger of oncogenesis, but strongly associated with other tumor-promoting mutations. Screening for IDH1 mutation can provide valuable information on diagnosis and prognosis of glioma. Glioma with IDH1 mutation tend to be less aggressive than glioma without IDH1 mutation.
|Antibody Type||Rabbit Monoclonal||Clone||RBT-IDH1|
|Presentation||IDH1 is a rabbit monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.|
|Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.|